ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,321.915
1.22%
Brent Oil
83.52
0.48%
Bitcoin
64,972.30
1.52%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Celgene Corporation (CELG)

  7. Celgene Corporation (CELG) News

Celgene (CELG)

Celgene Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CELG
DateTimeSourceHeadlineSymbolCompany
16/12/201912:30GlobeNewswire Inc.NexImmune Appoints Sol Barer as Chairman of the Board of DirectorsNASDAQ:CELGCelgene Corporation
21/11/201911:21PR Newswire (US)Amgen Completes Acquisition Of Otezla® (apremilast)NASDAQ:CELGCelgene Corporation
20/11/201921:18Business WireCelgene Announces Plans to Transfer Listing of Celgene’s Contingent Value Rights Following Closing of Acquisition by Bristo...NASDAQ:CELGCelgene Corporation
20/11/201919:09Business WireCELGENE ERHÄLT DIE ZULASSUNGSEMPFEHLUNG DES CHMP FÜR LENALIDOMID (REVLIMID®) IN KOMBINATION MIT RITUXIMAB ZUR BEHANDLUNG V...NASDAQ:CELGCelgene Corporation
19/11/201916:16PR Newswire (US)Thermo Fisher Scientific Set to Join S&P 100; ServiceNow to Join S&P 500NASDAQ:CELGCelgene Corporation
18/11/201922:10GlobeNewswire Inc.Exelon Corporation to Join the NASDAQ-100 Index Beginning November 21, 2019NASDAQ:CELGCelgene Corporation
15/11/201922:39Dow Jones NewsFTC Requires Bristol-Meyers Squibb, Celgene to Divest Otezla as Condition of AcquisitionNASDAQ:CELGCelgene Corporation
15/11/201913:22Dow Jones NewsCelgene Gets CHMP Positive Opinion for Revlimid/Rituximab Combo in Follicular LymphomaNASDAQ:CELGCelgene Corporation
15/11/201912:30Business WireCelgene Receives CHMP Positive Opinion for REVLIMID® (lenalidomide) in Combination With Rituximab for the Treatment of Adult...NASDAQ:CELGCelgene Corporation
13/11/201903:28PR Newswire (Canada)Skyhawk Therapeutics annonce une deuxième entente de collaboration multicible avec Celgene pour découvrir et mettre au poin...NASDAQ:CELGCelgene Corporation
12/11/201914:00PR Newswire (US)Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...NASDAQ:CELGCelgene Corporation
12/11/201914:00PR Newswire (Canada)Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...NASDAQ:CELGCelgene Corporation
08/11/201918:30Dow Jones NewsAcceleron Pharma Shares Gain Ground After FDA Approves ReblozylNASDAQ:CELGCelgene Corporation
08/11/201918:20Dow Jones NewsFDA Approves Celgene's and Acceleron's Reblozyl to Treat Rare Blood DisorderNASDAQ:CELGCelgene Corporation
08/11/201917:33Business WireFDA Approves REBLOZYL® (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular R...NASDAQ:CELGCelgene Corporation
06/11/201921:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
06/11/201914:06Business WireCelgene to Present New & Updated Data on Key Hematology Pipeline Therapies at American Society of Hematology (ASH) 2019 Annua...NASDAQ:CELGCelgene Corporation
04/11/201921:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
04/11/201921:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
04/11/201921:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
04/11/201921:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
04/11/201921:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
31/10/201920:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELGCelgene Corporation
31/10/201911:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELGCelgene Corporation
31/10/201911:30Business WireCelgene Reports Third Quarter 2019 Operating and Financial ResultsNASDAQ:CELGCelgene Corporation
16/10/201911:00Business WireCelgene & the Multiple Sclerosis Association of America Take the MS MindShift Initiative & “Brain Bulb” Hot Air Balloon t...NASDAQ:CELGCelgene Corporation
20/09/201912:30Business WireCelgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant RecipientsNASDAQ:CELGCelgene Corporation
19/09/201921:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
12/09/201921:30Business WireCelgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myel...NASDAQ:CELGCelgene Corporation
11/09/201917:24Dow Jones NewsSwiss Biotech Anokion Raises $40 Million in Series B RoundNASDAQ:CELGCelgene Corporation
 Showing the most relevant articles for your search:NASDAQ:CELG

Your Recent History

LSE
POS
Plexus
LSE
BIRD
Blackbird
LSE
SRSP
Sirius Petroleum
LSE
SBTX
Skinbiotherapeutics
LSE
AAU
Ariana Resources
LSE
ENET
Ethernity Networks
LSE
SCE
Surface Transforms
LSE
INSG
Insig Ai
LSE
AGL
Angle
LSE
HUM
Hummingbird Resources
LSE
GFM
Griffin Mining
LSE
SOLG
Solgold
LSE
OBI
Ondine Biomedical
LSE
SCLP
Scancell
LSE
LLOY
Lloyds Banking
LSE
OXB
Oxford Biomedica
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved